Serum apelin levels in patients with thyroid dysfunction

dc.contributor.authorGurel, Ali
dc.contributor.authorDogantekin, Akif
dc.contributor.authorOzkan, Yusuf
dc.contributor.authorAydin, Suleyman
dc.date.accessioned2026-08-12T17:04:24Z
dc.date.issued2015
dc.departmentFırat Üniversitesi
dc.description.abstractAdipocytes are not only for energy storage, but are also functionally active cells, producing biologically active peptides called adipocytokines. Adipocytokines control nutrition, thermogenesis, immunity, thyroid and reproductive hormones, and neuroendocrine functions. One of the most important new members of this family is apelin. In patients with thyroid dysfunctions, there are usually changes in weight, thermogenesis and adipose tissue lipolysis. Here, we investigated the serum apelin levels in different thyroid hormone states. Our study group consisted of the following patients: 32 thyrotoxicosis, 32 subclinical hyperthyroidism, 31 hypothyroidism, 34 subclinical hypothyroidism and 31 healthy control cases. In addition to routine blood tests, serum free 13 (FT3), free 14 (FT4), TSH and apelin levels were measured, and the body mass index (BMI) was recorded. In terms of the demographic characteristics, age and BMI, there was no statistically significant difference between the groups (P>0.05). The mean serum apelin levels of the groups were as follows: thyrotoxicosis group, 4.6 1.9 ng/ml; subclinical hyperthyroidism group, 3.7 1.9 ng/mi; hypothyroid group, 4.8 2.5 ng/mi; subclinical hypothyroidism group, 4.3 2.2 ng/mL; and control group, 3.4+1.4 ng/ml, respectively. There was no statistically significant difference in terms of the mean apelin levels between the groups (P>0.05). The hypothyroid group had the highest and the control group had the lowest mean apelin levels. As a result, the apelin levels were higher in both the patients with hypothyroidism and hyperthyroidism, in comparison with the normal population, but without statistical significance.
dc.identifier.endpage16398
dc.identifier.issn1940-5901
dc.identifier.issue9
dc.identifier.pmid26629164
dc.identifier.scopus2-s2.0-84946594893
dc.identifier.scopusqualityN/A
dc.identifier.startpage16394
dc.identifier.urihttps://hdl.handle.net/11508/48711
dc.identifier.volume8
dc.identifier.wosWOS:000365273300103
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherE-Century Publishing Corp
dc.relation.ispartofInternational Journal of Clinical and Experimental Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectThyroid dysfunction
dc.subjectapelin
dc.subjectmetabolic disorders
dc.titleSerum apelin levels in patients with thyroid dysfunction
dc.typeArticle

Dosyalar